Literature DB >> 2196510

Age-related maculopathy. I: A review of its morphology and effects on visual function.

P G Swann1, J E Lovie-Kitchin.   

Abstract

Age-related maculopathy (ARM) is a leading cause of permanent vision loss in elderly people. ARM therefore constitutes an important public health problem which will increase in magnitude as the number of aged people in the general population becomes greater. The consequences of this condition are exacerbated by the fact that treatment, especially of the atrophic form of the disease, is ineffective. While laser photocoagulation may be helpful in the exudative form of ARM, there is often an inexorable progression towards severe vision loss in these patients. Therefore considerable attention needs to be paid to the aetiology of ARM, the potential for its prevention or delayed onset and its recognition through functional disturbances. This is the first of three papers dealing with ARM and its effects on visual function. We review its morphology and the visual disturbances that may ensue. The second and third papers will discuss the nature and detection of the central visual field loss due to ARM.

Entities:  

Mesh:

Year:  1990        PMID: 2196510     DOI: 10.1111/j.1475-1313.1990.tb00969.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  5 in total

1.  Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?

Authors:  M E McClure; P M Hart; A J Jackson; M R Stevenson; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Monocular optokinetic nystagmus in humans with age-related maculopathy.

Authors:  R V Abadi; M Pantazidou
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

Review 3.  The genetics of inherited macular dystrophies.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

4.  Parafoveal letter recognition at reduced contrast in normal aging and in patients with risk factors for AMD.

Authors:  Gesa Astrid Hahn; Andre Messias; Manfred Mackeben; Klaus Dietz; Karin Horwath; Lea Hyvärinen; Markku Leinonen; Susanne Trauzettel-Klosinski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-28       Impact factor: 3.117

Review 5.  Anecortave acetate in the treatment of age-related macular degeneration.

Authors:  Albert Augustin
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.